7
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Monoamine Oxidase Inhibitors: 30 Years Of Progress?

Pages 179-185 | Published online: 11 Jul 2009
 

Abstract

It is just over 30 years since MAOIs were first introduced into clinical practice in the United Kingdom. Early work suggested their usefulness in atypical states and in patients with reverse biological symptoms. Despite controversy the literature has persistently shown their continuing usefulness in these groups. Certain groups of patients with phobic symptoms are also probably helped. But controversy remains concerning other groups of patients. Combination therapy would now probably be considered safe and effective if carefully supervised and fears about the tyramine reaction are probably exaggerated.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.